NEW YORK (GenomeWeb) – Agilent Technologies today announced that its board has approved a share repurchase program for up to a $1.14 billion. 

The buyback program will run through Nov. 1, 2018 and will begin either on Nov. 1, 2015 or when Agilent's previous buyback program is completed. The existing program has $365 million remaining, the Santa Clara, California-based firm said. 

Earlier this month, Agilent reported a 3 percent drop in its fiscal second quarter revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.